Google Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) and Swiss drugmaker Novartis AG (ADR) (NYSE:NVS) (VTX:NOVN) have announced an amazing development, one sure to be a significant point of differentiation in Google’s plans to beat Apple Inc. (NASDAQ:AAPL) and Samsung Electronics Co. Ltd. (LON:BC94) (KRX:0059935) in the race to control consumers healthcare applications. The product under joint development is “smart” contact lenses that track blood glucose levels or restore the eye’s ability to focus, Reuters is reporting. Novartis partners with Google to develop contact lens Novartis AG (ADR) (NYSE:NVS) (VTX:NOVN), said to be the lead developer of the medical technology with Google Inc (NASDAQ:GOOG)…
Google, Novartis Partner To Revolutionize Healthcare
Mark Melin
Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.